Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus
Publication date: Available online 16 June 2021Source: MitochondrionAuthor(s): Konstantin N. Belosludtsev, Vlada S. Starinets, Maxim N. Belosludtsev, Irina B. Mikheeva, Mikhail V. Dubinin, Natalia V. Belosludtseva
Source: Mitochondrion - Category: Biochemistry Source Type: research
More News: Biochemistry | Dapagliflozin | Diabetes | Diabetes Mellitus | Diets | Endocrinology | Forxiga | High Fat | Liver | Nutrition | Urology & Nephrology